Molecular typing of stage IB non-small-cell lung cancer for precision medicine.

The median OS time was 51 months in stage IB2, and not reached in stage IB1, but the difference in OS did not reach statistical significance (HR, 1.704; 95% CI, 0.631 to 4.599) ( Figure 1D ).

also in 111,027 other papers

The results in both datasets are consistent and highly significant, regardless of whether using the data-based optimal threshold method or the continuous variable analysis method ( Supplementary Figures 5A–F ). 3.8.

also in 132,142 other papers